Product Name: GS-441524 Sterile Injection
Strength: 20mg/ml × 6ml; 20mg/ml × 8ml; 20mg/ml × 10ml; 30mg/ml × 6ml; 30mg/ml × 8ml; 30mg/ml ×10ml
Package: 10 PCS/box
For Use In: Cats
Actions & Indications:
For the treatment of naturally occurring feline infectious peritonitis in cats, including:
Effusive (wet) FIP
Non-effusive (dry) FIP
FIP with ocular or neurological involvement (dose adjustment may be required)

Dosage:
Recommended Dosage
4.0 mg/kg body weight, once every 24 hours, by subcutaneous injection
Treatment Duration
At least 12 consecutive weeks

Body weight (kg)	Dose per Administration(mg)	Volume for 20mg/ml (ml)	Volume for 30mg/ml (ml)
1.0-2.0	4-8	0.2-0.4	0.13-0.27
2.0-3.0	8-12	0.4-0.6	0.27-0.40
3.0-40	12-16	0.6-0.8	0.40-0.53
4.0-5.0	16-20	0.8-1.0	0.53-0.67
5.0-6.0	20-24	1.0-1.2	0.67-0.80
6.0-7.0	24-28	1.2-14	0.80-0.93
>7.0	Calculate by weight	Proportional	Proportional

Special Dosage Instructions:
Forcatswithocular orneurologicalsigns,adosageof4.0 mg/kgorhigherisrecommendedunder veterinarysupervision,withconsiderationofextendedtreatmentduration.

Treatment Response:
Accordingtoclinicalstudies (Pedersen et al., 2019):
Bodytemperaturereturnsto normal within 12–36hours in most cats
Appetite,activity level, andbody weight improve significantly within 1–2 weeks
Abdominalorthoracic effusion resolves graduallywithin 1–2 weeks
Serumalbumin andA/Gratio normalizewithin 8–10 weeks
Over80%ofcats completing 12weeksormore of treatment achieve long-term
Adverse Reactions:
InjectionSiteReactions
Localswelling, scabbing,or ulceration,mostcommon in the first few weeks of treatment
Incidenceapproximately60%,withopensores occurringin about25%ofcases
Usuallyhealwithin2weekswithsupportivecare(local cleaning, rotation of injection sites)

Precautions:
1.This is a prescription drug and must be used under veterinary supervision
2.Regular monitoring of body weight, serum albumin, A/G ratio, and complete blood count is recommended during treatment
3.For cats with ocular or neurological signs, individualized treatment plans should be developed under specialist supervision
4.The injectable solution has a low pH (approximately 1.5) and may cause transient pain upon injection;rotation of injection sites is recommended
5.Not recommended for use in pregnant or lactating cats due to insufficient safety data

Discontinuation:
After treatment completion, observation for at least 3 months is recommended. Veterinary re-evaluation is advised if any of the following occur:
Weight loss
Fever
Decreased appetite
Lethargy
Abdominal distension or dyspnea

For animal use only.